Discovery of (R)-4-Cyclopropyl-7;8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over NotchJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-06-2029PRE
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's diseaseALZHEIMERS RESEARCH & THERAPYIF7.62010-12-2946OAAI
Identification of γ-secretase inhibitor potency determinants on presenilinJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92008-02-0159OAAI
Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonistsJOURNAL OF MEDICINAL CHEMISTRYIF6.82007-09-1942PREAI